Summary

The Vietnam tuberculosis therapeutics market is anticipated to register a robust growth in the forecast period, 2023-2027. Growing demands for effective treatment and efficient pharmaceuticals to control the growing instances of tuberculosis is driving the market growth. Besides, increasing investments and grants for tuberculosis therapeutics are boosting the growth of the Vietnam tuberculosis therapeutics market. Earlier, tuberculosis has been a leading cause of death in Vietnam. The government is aggressively implementing programs and initiatives to control the tuberculosis rates such as the National Tuberculosis Control Programme (NTP). Rising government measures and growing public awareness of communicable illnesses are also expected to fuel the Vietnam tuberculosis therapeutics market. Rising incidences of drug susceptible tuberculosis and increase in multi-drug resistant TB cases are some of the factors boosting the market growth. Besides. More R&D efforts towards drug development, emergence of effective drug alternatives in the market, and collaborations focused on the development of shorter treatment regimens to fight resistance and address unmet medical needs, which are expected to fuel the market growth.
The Vietnam tuberculosis therapeutics market is segmented on the basis of disease type, therapy, competitive landscape, and regional distribution. Based on disease type, the market is divided between active tuberculosis and latent tuberculosis. The most common cause of tuberculosis in the general population is Mycobacterium tuberculosis. The prevalence of Mycobacterium tuberculosis in South Asian nations like Vietnam, India, Laos, etc., is a significant contributor to the rise in tuberculosis cases and, consequently, the demand for tuberculosis medicines. Active tuberculosis patients have a propensity to spread the illness to others. Patients with latent tuberculosis, however, do not have this tendency.
The major market players operating in the Vietnam tuberculosis therapeutics market are Novartis Vietnam Co., Ltd., Johnson & Johnson, Otsuka Pharmaceutical Vietnam JSC, Lupin Limited, and GSK Vietnam.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023–2027
Objective of the Study:
• To analyze the historical growth in the market size of the Vietnam tuberculosis therapeutics from 2017 to 2021.
• To estimate and forecast the market size of Vietnam tuberculosis therapeutics market from 2023 to 2027 and growth rate until 2027.
• To classify and forecast the Vietnam tuberculosis therapeutics market based on disease type, therapy, region, and company.
• To identify the dominant region or segment in the Vietnam tuberculosis therapeutics market.
• To identify drivers and challenges for the Vietnam tuberculosis therapeutics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Vietnam tuberculosis therapeutics market.
• To identify and analyze the profiles of leading players operating in the Vietnam tuberculosis therapeutics market.
• To identify key sustainable strategies adopted by market players in Vietnam tuberculosis therapeutics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed service providers and presence of all major players across the country.
TechSci Research calculated the market size of the Vietnam tuberculosis therapeutics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, Vietnam tuberculosis therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Vietnam Tuberculosis Therapeutics Market, By Disease Type:
o Active Tuberculosis
o Latent Tuberculosis
• Vietnam Tuberculosis Therapeutics Market, By Therapy:
o First Line Therapy
o Second Line Therapy
• Vietnam Tuberculosis therapeutics Market, By Region:
o Northern Region
o Central Region
o Southern Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Vietnam tuberculosis therapeutics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Vietnam Tuberculosis Therapeutics Market
4. Executive Summary
5. Voice of Customers
6. Vietnam Tuberculosis Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Type (Active Tuberculosis v/s Latent Tuberculosis)
6.2.2. By Therapy (First Line Therapy v/s Second Line Therapy)
6.2.3. By Region
6.2.4. By Company (2021)
6.3. Product Market Map
7. Vietnam Active Tuberculosis Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
8. Vietnam Latent Tuberculosis Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. Vietnam Economic Profile
13. Competitive Landscape
13.1. Novartis Vietnam Co., Ltd.
13.2. Johnson & Johnson
13.3. Otsuka Pharmaceutical Vietnam JSC
13.4. Lupin Limited
13.5. GSK Vietnam
14. Strategic Recommendations
(Note: The companies list can be customized based on the client requirements.)